Format

Send to

Choose Destination
Eur J Nutr. 2018 Apr;57(3):929-938. doi: 10.1007/s00394-016-1376-9. Epub 2017 Feb 16.

Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects.

Author information

1
Increnovo LLC, 2138 E Lafayette Pl, Milwaukee, WI, 53202, USA.
2
Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL, 33606, USA.
3
Centre for Health Research, School of Medicine, Western Sydney University, Campbelltown, NSW, 2560, Australia.
4
National Institute of Complementary Medicine, Western Sydney University, Campbelltown, NSW, 2560, Australia. g.muench@westernsydney.edu.au.
5
Molecular Medicine Research Group, School of Medicine, Western Sydney University, Campbelltown, NSW, 2560, Australia. g.muench@westernsydney.edu.au.
6
National Institute of Complementary Medicine, Western Sydney University, Campbelltown, NSW, 2560, Australia.
7
South Western Sydney Clinical School, School of Medicine, The University of New South Wales, Sydney, NSW, 2052, Australia.

Abstract

PURPOSE:

The optimal health benefits of curcumin are limited by its low solubility in water and corresponding poor intestinal absorption. Cyclodextrins (CD) can form inclusion complexes on a molecular basis with lipophilic compounds, thereby improving aqueous solubility, dispersibility, and absorption. In this study, we investigated the bioavailability of a new γ-cyclodextrin curcumin formulation (CW8). This formulation was compared to a standardized unformulated curcumin extract (StdC) and two commercially available formulations with purported increased bioavailability: a curcumin phytosome formulation (CSL) and a formulation of curcumin with essential oils of turmeric extracted from the rhizome (CEO).

METHODS:

Twelve healthy human volunteers participated in a double-blinded, cross-over study. The plasma concentrations of the individual curcuminoids that are present in turmeric (namely curcumin, demethoxycurcumin, and bisdemethoxycurcumin) were determined at baseline and at various intervals after oral administration over a 12-h period.

RESULTS:

CW8 showed the highest plasma concentrations of curcumin, demethoxycurcumin, and total curcuminoids, whereas CSL administration resulted in the highest levels of bisdemethoxycurcumin. CW8 (39-fold) showed significantly increased relative bioavailability of total curcuminoids (AUC0-12) in comparison with the unformulated StdC.

CONCLUSION:

The data presented suggest that γ-cyclodextrin curcumin formulation (CW8) significantly improves the absorption of curcuminoids in healthy humans.

KEYWORDS:

Bioavailability; Curcumin; Cyclodextrin; Humans; Plasma pharmacokinetics

PMID:
28204880
PMCID:
PMC5861163
DOI:
10.1007/s00394-016-1376-9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center